Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Arnold

Showing results (81-90 of 233) with videos related to

Pageof 24
Sort By:
Clinical Colorectal Cancer|August 27, 2018
Impact of the Localization of the Primary Tumor and RAS/BRAF Mutational Status on Maintenance Strategies After First-line Oxaliplatin, Fluoropyrimidine, and Bevacizumab in Metastatic Colorectal Cancer: Results From the AIO 0207 TrialStefanie Noepel-Duennebacke, Dirk Arnold, Jan Hertel, et al.
Sensors (Basel, Switzerland)|October 19, 2019
Comparison between Intramuscular Multichannel Electrodes and Supramysial Multichannel Electrodes via EMG Measurements for Potential Use as Larynx Stimulation Electrodes: In Vivo Animal AnalysisBernd Faenger, Nikolaus P Schumann, Christoph Anders, et al.
Onkologie|September 13, 2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatmentMartin R Weihrauch, Dirk Stippel, Jochen W U Fries, et al.
Onkologie|December 17, 2008
[Surgical and perioperative therapy of liver metastases]Hans Jürgen Schlitt, Dirk Arnold, Wolfram T Knoefel, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 31, 2012
Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseasesAndreas Gunter Bach, Curd Behrmann, Hans Jürgen Holzhausen, et al.
Clinical Epidemiology|May 7, 2015
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort studyNorbert Marschner, Dirk Arnold, Erik Engel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trialsChristian Weiss, Dirk Arnold, Kathrin Dellas, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Selective Surface Electrostimulation of the Denervated Zygomaticus MuscleDirk Arnold, Jovanna Thielker, Carsten M Klingner, et al.
Psycho-Oncology|October 23, 2024
Effects of Mobile Application-Based Cognitive Behavioral Therapy on Psychological Outcomes in Women Treated for Breast Cancer: A Randomized Controlled Pilot Trial in GermanyRia Heinrich, Georgia Schilling, Ewa Wojtyna, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 2, 2021
Accessing the Stapedius Muscle Via Novel Surgical Retrofacial Approach: A Cadaveric Feasibility StudyDirk Arnold, Fritz Schneider, Gerd Fabian Volk, et al.
Pageof 24

Showing results (81-90 of 233) with videos related to

Sort By:
Pageof 24
Clinical Colorectal Cancer|August 27, 2018
Impact of the Localization of the Primary Tumor and RAS/BRAF Mutational Status on Maintenance Strategies After First-line Oxaliplatin, Fluoropyrimidine, and Bevacizumab in Metastatic Colorectal Cancer: Results From the AIO 0207 TrialStefanie Noepel-Duennebacke, Dirk Arnold, Jan Hertel, et al.
Sensors (Basel, Switzerland)|October 19, 2019
Comparison between Intramuscular Multichannel Electrodes and Supramysial Multichannel Electrodes via EMG Measurements for Potential Use as Larynx Stimulation Electrodes: In Vivo Animal AnalysisBernd Faenger, Nikolaus P Schumann, Christoph Anders, et al.
Onkologie|September 13, 2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatmentMartin R Weihrauch, Dirk Stippel, Jochen W U Fries, et al.
Onkologie|December 17, 2008
[Surgical and perioperative therapy of liver metastases]Hans Jürgen Schlitt, Dirk Arnold, Wolfram T Knoefel, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 31, 2012
Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseasesAndreas Gunter Bach, Curd Behrmann, Hans Jürgen Holzhausen, et al.
Clinical Epidemiology|May 7, 2015
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort studyNorbert Marschner, Dirk Arnold, Erik Engel, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trialsChristian Weiss, Dirk Arnold, Kathrin Dellas, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Selective Surface Electrostimulation of the Denervated Zygomaticus MuscleDirk Arnold, Jovanna Thielker, Carsten M Klingner, et al.
Psycho-Oncology|October 23, 2024
Effects of Mobile Application-Based Cognitive Behavioral Therapy on Psychological Outcomes in Women Treated for Breast Cancer: A Randomized Controlled Pilot Trial in GermanyRia Heinrich, Georgia Schilling, Ewa Wojtyna, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 2, 2021
Accessing the Stapedius Muscle Via Novel Surgical Retrofacial Approach: A Cadaveric Feasibility StudyDirk Arnold, Fritz Schneider, Gerd Fabian Volk, et al.
Pageof 24